Small molecules for neural stem cells

Apr 23, 2012
Small molecules for neural stem cells
Credit: Thinkstock

European scientists used chemical genetics to discover molecules that could serve as future regenerative medicines to treat neurological and neurodegenerative diseases.

Stem cells hold tremendous potential in regenerative medicine for and therapy. However, despite extensive research, manipulation and maintenance of the stem cell properties still pose a challenge to scientists worldwide.

Small can substitute for biological signalling factors for the maintenance of mouse and a similar approach is believed to hold for other stem . Chemical modulators augmenting the growth, survival or differentiation of have a prospect as preventative or regenerative strategies for . Similarly, inhibitor compounds may serve to block the growth of neural cancer stem cells.

The ultimate aim of the EU-funded project ‘The discovery of future neuro-therapeutic molecules’ (Neuroscreen) was to discover potential drugs of relevance to neurological diseases, regenerative medicine and cancer. More specifically, project partners focused on designing unique bioassays in order to develop and evaluate the biological modulating capacity of small molecules.

These molecules were designed and synthesised using advanced chemistry and tested on rodent and human neural cell lines before moving on to neural stem cells. Partners proposed that small compounds had enormous commercial potential as they would enter the market through a rather expedited process and would serve as culture media additives, reducing the cost of stem cell culture.

Furthermore, procedures for checking the quality of neural stem cells were standardised and a storage facility was established. This ensured consistency in the source of biological material.

Neuroscreen set up a successful workflow starting from unique bioassays and a stem cell bank to automated screening of small compounds. These tools will prove essential for translating knowledge into new products, processes and services, benefiting patients and improving public health.

Explore further: The anti-inflammatory factory

add to favorites email to friend print save as pdf

Related Stories

New study hopeful on neural stem cells

Aug 05, 2006

Neural stem cells derived from federally approved human embryonic cells are inferior to stem cells derived from donated fetal tissue, a new study found.

Identification of a novel neural stem cell type

Jan 14, 2008

As published in the upcoming issue of G&D, sesearchers from the Sloan-Kettering Institute, led by Dr. Lorenz Studer, have discovered a novel type of neural stem cell, which has a broader differentiation potential than previously ...

Recommended for you

The anti-inflammatory factory

Apr 22, 2014

Russian scientists, in collaboration with their colleagues from Pittsburgh University, have discovered how lipid mediators are produced. The relevant paper was published in Nature Chemistry. Lipid mediators are molecules that p ...

User comments : 0

More news stories

When things get glassy, molecules go fractal

Colorful church windows, beads on a necklace and many of our favorite plastics share something in common—they all belong to a state of matter known as glasses. School children learn the difference between ...

FCC to propose pay-for-priority Internet standards

The Federal Communications Commission is set to propose new open Internet rules that would allow content companies to pay for faster delivery over the so-called "last mile" connection to people's homes.

SK Hynix posts Q1 surge in net profit

South Korea's SK Hynix Inc said Thursday its first-quarter net profit surged nearly 350 percent from the previous year on a spike in sales of PC memory chips.